kabutan

RaQualia Pharma, First Half Ordinary Profit Loss Widens, Apr-Jun Ordinary Profit Loss Widens

Thu Aug 14, 2025 3:30 pm JST Earnings

4579 RaQualia Pharma Inc. 【J-GAAP】

Earnings Report

RaQualia Pharma Inc. <4579> [TSE Growth] announced its financial results after the market closed on August 14th (15:30). The consolidated ordinary loss for the cumulative second quarter of the fiscal year ending December 2025 (January to June) expanded to a loss of 291 million yen (compared to a loss of 277 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the July to December period (second half) is expected to turn into a profit of 364 million yen (compared to a loss of 84 million yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the consolidated ordinary loss expanded to a loss of 320 million yen (compared to a loss of 200 million yen in the same period last year). The operating profit/loss margin drastically worsened from -26.0% in the same period last year to -49.6%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 1,014 -23 36 25 1.2 ー Aug 10, 2023 J-GAAP
Jan - Jun, 2024 1,411 -154 -277 -323 -15.0 ー Aug 14, 2024 J-GAAP
Jan - Jun, 2025 1,535 -190 -291 -354 -15.5 ー Aug 14, 2025 J-GAAP
YoY +8.8% -23.4% -5.1% -9.6% -3.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 J-GAAP
Jan - Jun, 2025 Results 1,535 -190 -291 -354 -15.5 0 Aug 14, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 1,696 -59 -84 -172 -8.0 0 Feb 14, 2025 J-GAAP
Jul - Dec, 2025 Guidance 2,353 308 364 283 11.6 0 Aug 14, 2025 J-GAAP
YoY +38.7% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,901 -337 -293 -323 -15.0 0 Feb 14, 2024 J-GAAP
Dec, 2024 3,107 -213 -361 -495 -22.9 0 Feb 14, 2025 J-GAAP
Dec, 2025 Guidance 3,888 118 73 -71 -2.9 0 Feb 14, 2025 J-GAAP
YoY +25.1% － － +85.7% +87.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 763 -198 -200 -245 -11.4 -26.0 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 958 127 46 -16 -0.7 13.3 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 738 -186 -130 -156 -7.2 -25.2 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 965 93 29 -5 -0.2 9.6 May 15, 2025 J-GAAP
Apr - Jun, 2025 570 -283 -320 -349 -15.3 -49.6 Aug 14, 2025 J-GAAP
YoY -25.3% -42.9% -60.0% -42.4% -34.5%

Related Articles